BGRF salutes its staff on launch of NAD+-focused research collaboration

(Biogerontology Research Foundation) The Biogerontology Research Foundation salutes its Chief Science Advisor Alex Zhavoronkov and Trustee Jim Mellon on the formation of Napa Therapeutics, a research collaboration with $100m+ commercialization potential between Juvenescence Limited (of which Jim Mellon is Chairman), Insilico Medicine Inc. (of which Alex Zhavoronkov is CEO), and the Buck Institute for Research on Aging.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2LdxRRL